These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 30744689)

  • 1. The role and mechanisms of action of microRNAs in cancer drug resistance.
    Si W; Shen J; Zheng H; Fan W
    Clin Epigenetics; 2019 Feb; 11(1):25. PubMed ID: 30744689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs Change the Landscape of Cancer Resistance.
    Zhu J; Zhu W; Wu W
    Methods Mol Biol; 2018; 1699():83-89. PubMed ID: 29086370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs: master regulators of drug resistance, stemness, and metastasis.
    Raza U; Zhang JD; Sahin O
    J Mol Med (Berl); 2014 Apr; 92(4):321-36. PubMed ID: 24509937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice.
    Giovannetti E; Erozenci A; Smit J; Danesi R; Peters GJ
    Crit Rev Oncol Hematol; 2012 Feb; 81(2):103-22. PubMed ID: 21546262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as therapeutic targets in chemoresistance.
    Garofalo M; Croce CM
    Drug Resist Updat; 2013; 16(3-5):47-59. PubMed ID: 23757365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of microRNAs in resistance to lung cancer treatments.
    MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
    Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of microRNAs in drug resistance for designing novel cancer therapy.
    Sarkar FH; Li Y; Wang Z; Kong D; Ali S
    Drug Resist Updat; 2010 Jun; 13(3):57-66. PubMed ID: 20236855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer.
    Rolfo C; Fanale D; Hong DS; Tsimberidou AM; Piha-Paul SA; Pauwels P; Van Meerbeeck JP; Caruso S; Bazan V; Cicero G; Russo A; Giovannetti E
    Curr Pharm Biotechnol; 2014; 15(5):475-85. PubMed ID: 24846062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs: novel mediators of resistance to microtubule-targeting agents.
    Kanakkanthara A; Miller JH
    Cancer Treat Rev; 2013 Apr; 39(2):161-70. PubMed ID: 22902296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
    Neelakandan K; Babu P; Nair S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The related miRNAs involved in doxorubicin resistance or sensitivity of various cancers: an update.
    Torki Z; Ghavi D; Hashemi S; Rahmati Y; Rahmanpour D; Pornour M; Alivand MR
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):771-793. PubMed ID: 34510251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and human cancer.
    Nikitina EG; Urazova LN; Stegny VN
    Exp Oncol; 2012; 34(1):2-8. PubMed ID: 22453141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathways involved in microRNA-mediated regulation of multidrug resistance.
    Liao R; Lin Y; Zhu L
    Mol Biol Rep; 2018 Dec; 45(6):2913-2923. PubMed ID: 30194558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in personalized cancer therapy.
    Sethi S; Ali S; Sethi S; Sarkar FH
    Clin Genet; 2014 Jul; 86(1):68-73. PubMed ID: 24635652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA and drug resistance.
    Ma J; Dong C; Ji C
    Cancer Gene Ther; 2010 Aug; 17(8):523-31. PubMed ID: 20467450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of microRNA in cancer and apoptosis.
    Lynam-Lennon N; Maher SG; Reynolds JV
    Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A summary for molecular regulations of miRNAs in breast cancer.
    Yahya SM; Elsayed GH
    Clin Biochem; 2015 Apr; 48(6):388-96. PubMed ID: 25541018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNAs as pharmacological targets in cancer.
    Soriano A; Jubierre L; Almazán-Moga A; Molist C; Roma J; de Toledo JS; Gallego S; Segura MF
    Pharmacol Res; 2013 Sep; 75():3-14. PubMed ID: 23537752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA: Promising Roles in Cancer Therapy.
    Hashemi A; Gorji-Bahri G
    Curr Pharm Biotechnol; 2020; 21(12):1186-1203. PubMed ID: 32310047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.